Arvinas

Price & Volume

Stats

52W Range	$5.90-$18.93
Market Cap	$976M
Shares Short	4M

Financials

Revenue (12 Mos)	$262.6M
Revenue Growth (YoY)	-84%
Gross Profit (12 Mos)	-$20.3M
Diluted EPS	-$0.81

News

Yahoo Finance • 4 days ago

Arvinas Q4 2025 Earnings Preview

Yahoo Finance • 15 days ago

Indian textile maker Welspun's profit nearly wiped out on US tariff-led slowdown

Yahoo Finance • 17 days ago

PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight

Yahoo Finance • 3 months ago

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

About

CEO	Dr. Randy Teel Ph.D.
CFO	Mr. Andrew R. Saik
Address	5 Science Park, New Haven, CT, United States, 06511
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	430